NEW YORK, NY -- (MARKET WIRE) -- December 11, 2006 -- NeoStem, Inc. (OTCBB: NEOI), a company specializing in the collection, processing and long-term storage of Adult Stem Cells (ASCs) for autologous use, announced today that it has appointed Stephen D. Nimer, MD, a prominent authority in hematologic oncology, to the Company's Scientific Advisory Board.
